Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company reported a net loss of $2.3 billion, or $0.42 per share, compared to net income of $8.6 billion, or $1.51 per share, last year. Adjusted loss per share was $0.17. Both revenues and earnings surpassed […]
“Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company reported a net loss of $2.3 billion, or $0.42 per share, compared to net income of $8.6 billion, or $1.51 per share, last year. Adjusted loss per share was $0.17. Both revenues and earnings surpassed […]
· October 31, 2023
Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today.
Revenues declined 42% year-over-year to $13.2 billion.
The company reported a net loss of $2.3 billion, or $0.42 per share, compared to net income of $8.6 billion, or $1.51 per share, last year. Adjusted loss per share was $0.17.
Both revenues and earnings surpassed projections but the stock stayed in red during premarket hours on Tuesday.
For the full year of 2023, Pfizer expects revenue of $58-61 billion and adjusted EPS of $1.45-1.65.
